Professor Delong Liu, MD, PhD, New York Medical College, United States of America
Journal of Hematology & Oncology is calling for submissions to our Collection on 'Phase I clinical trials.'
Join us in shaping the future of early-phase clinical research and accelerating the translation of promising therapies from bench to bedside.
Journal of Hematology & Oncology is calling for submissions to our Collection on 'Phase I clinical trials.'
We invite submissions for the collection of research, review, and correspondence articles dedicated to Phase I clinical trials in the fields of either oncology or hematology. As Phase I trials lead the way for novel therapies, we welcome contributions on diverse topics such as novel agents, innovative trial designs, and biomarker development. Join us in shaping the future of early-phase clinical research and accelerating the translation of promising therapies from bench to bedside.
Image credit: © kentoh / Getty Images / iStock
There are currently no articles in this collection.
This Collection welcomes submission of Research, Review, and Correspondence articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal.
Articles for this Collection should be submitted via our submission system, Snapp. Please, select the appropriate Collection title “Phase I clinical trials" under the “Details” tab during the submission stage.
Articles will undergo the journal’s standard peer-review process and are subject to all the journal’s standard policies. Articles will be added to the Collection as they are published. The Editor has no competing interests with the submissions which are handled through the peer-review process. The peer-review of any submissions for which the Editor has competing interests is handled by another Editorial Board Member who has no competing interests.